Yeray Rioja Díez
YOU?
Author Swipe
View article: 4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy
4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy Open
Background and Importance Ustekinumab is approved for adult patients with moderately-severe active Crohn's disease (CD) at a usual dosing schedule of 90 mg every 8 to 12 weeks subcutaneously. Some patients may experience a partial response…
View article: 2SPD-005 Alternative to the treatment of poor graft function after haematopoietic stem cell transplantation: eltrombopag
2SPD-005 Alternative to the treatment of poor graft function after haematopoietic stem cell transplantation: eltrombopag Open
Background and Importance Poor graft function is a rare and serious complication in patients who have undergone haematopoietic stem cell transplantation (HSCT). It is characterised by moderate to severe cytopenias (haemoglobin less than 10…
View article: 4CPS-195 Characterisation of injectable formulations and optimisation of their delivery by enteral tube: a physicochemical and physiological approach
4CPS-195 Characterisation of injectable formulations and optimisation of their delivery by enteral tube: a physicochemical and physiological approach Open
Background and Importance Oral administration of injectables is an alternative for patients with difficulties tolerating solid pharmaceutical forms. Due to their physicochemical characteristics not adapted to oral administration, gastroint…
View article: 2SPD-007 Use of drugs in special situations
2SPD-007 Use of drugs in special situations Open
Background and Importance The use of medications in special situations is a common practice worldwide, even though it is a field with very few published studies at present. A lot of effort is spent daily in hospital pharmacy services to pr…